AINE y riesgo digestivo
Marcén, Beatriz; Sostres, Carlos; Lanas, Angel.
Aten. prim. (Barc., Ed. impr.)
; 48(2): 73-76, feb. 2016. tab
Artículo en Español | IBECS (España) | ID: ibc-148390
Documentos relacionados
NSAIDs, gastrointestinal toxicity and inflammatory bowel disease.
Primary repair of nonsteroidal anti-inflammatory drug-associated full thickness gastrointestinal ulcers in 11 dogs.
Gastrointestinal damage by non-steroidal anti-inflammatory drugs: updated clinical considerations.
Incident peptic ulcers and concomitant treatment of direct oral anticoagulants and oral bisphosphonates-a real-world cohort study.
Prevention of the gastrointestinal adverse effects of nonsteroidal anti-inflammatory drugs: the role of proton pump inhibitors.
PPIs and Safety Concerns - A Pending Verdict?
Accuracy of International Classification of Diseases, 9th Revision, Clinical Modification codes for upper gastrointestinal complications varied by position and age: a validation study in a cohort of nonsteroidal anti-inflammatory drugs users in Friuli Venezia Giulia, Italy.
Assessing causality between osteoarthritis and gastrointestinal disorders: a Mendelian randomization study.
[Recommendation for the prevention and treatment of non-steroidal anti-inflammatory drug-induced gastrointestinal ulcers and its complications].
Derivation and validation of a risk prediction score for nonsteroidal anti-inflammatory drug-related serious gastrointestinal complications in the elderly.